942 related articles for article (PubMed ID: 29221886)
1. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
2. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.
van Vugt JLA; Buettner S; Alferink LJM; Bossche N; de Bruin RWF; Darwish Murad S; Polak WG; Metselaar HJ; IJzermans JNM
Transpl Int; 2018 Feb; 31(2):165-174. PubMed ID: 28871624
[TBL] [Abstract][Full Text] [Related]
3. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.
Durand F; Buyse S; Francoz C; Laouénan C; Bruno O; Belghiti J; Moreau R; Vilgrain V; Valla D
J Hepatol; 2014 Jun; 60(6):1151-7. PubMed ID: 24607622
[TBL] [Abstract][Full Text] [Related]
5. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
Tandon P; Ney M; Irwin I; Ma MM; Gramlich L; Bain VG; Esfandiari N; Baracos V; Montano-Loza AJ; Myers RP
Liver Transpl; 2012 Oct; 18(10):1209-16. PubMed ID: 22740290
[TBL] [Abstract][Full Text] [Related]
6. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
[TBL] [Abstract][Full Text] [Related]
7. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
8. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk.
Sinclair M; Hoermann R; Peterson A; Testro A; Angus PW; Hey P; Chapman B; Gow PJ
Liver Int; 2019 Jun; 39(6):1089-1097. PubMed ID: 30746903
[TBL] [Abstract][Full Text] [Related]
9. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
[TBL] [Abstract][Full Text] [Related]
10. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
[TBL] [Abstract][Full Text] [Related]
11. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
[TBL] [Abstract][Full Text] [Related]
12. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
14. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
[TBL] [Abstract][Full Text] [Related]
15. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
16. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.
Salvalaggio P; Afonso RC; Pereira LA; Ferraz-Neto BH
Einstein (Sao Paulo); 2012; 10(3):278-85. PubMed ID: 23386004
[TBL] [Abstract][Full Text] [Related]
17. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
18. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
19. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
20. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
